Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

Direct Payment

$100,000.00

The safety and efficacy of human induced pluripotent stem cell transplantation after stroke.

FY 2011-12

Summary
Stroke is a leading cause of death and disability. A stroke occurs every 10 minutes in Canada with approximately 50,000 new cases occurring annually. It is necessary to find a treatment that can improve the quality of life for stroke patients. Stem cell therapy is a promising intervention. However, there is controversy surrounding the use of human fetal and embryonic stem cells. Significant optimism exists that induced pluripotent stem (iPS) cells, which can be created by introducing four transcription factors into fully developed adult cells, could be an effective treatment for brain injury. The appeal of iPS cells is enhanced by several factors, such as reducing the concern for stem cell shortage and the ethical concerns over the need for human embryonic cells. Furthermore, it will be possible to generate iPS cells from a patient's own tissue, negating the need for immunosuppressant drugs. The current project will study the 1) safety, 2) integration, and 3) efficacy and mechanisms of action of human iPS cells in a rodent model of stroke. In these studies human fetal and embryonic stem cells, which improve outcome following rodent models of stroke, will be compared to human iPS cells. We will first assess the risk of tumor formation following cell treatment after stroke in mice. Then we will compare the different cell treatments following rodent stroke, looking for differences in cell survival, migration, and differentiation. In the final study functional outcome and mechanisms of action such as changes in plasticity.
Program
CIHR Fellowship
Location
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
242699
Name
Auriat Angela M
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
The safety and efficacy of human induced pluripotent stem cell transplantation after stroke.
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Clinical Translation; Functional Outcome; Human Induced Pluripotent Stem Cells; Ischemia; Plasticity; Recovery; Stem Cells; Stroke; Transplantation
Abstract
Stroke is a leading cause of death and disability. A stroke occurs every 10 minutes in Canada with approximately 50,000 new cases occurring annually. It is necessary to find a treatment that can improve the quality of life for stroke patients. Stem cell therapy is a promising intervention. However, there is controversy surrounding the use of human fetal and embryonic stem cells. Significant optimism exists that induced pluripotent stem (iPS) cells, which can be created by introducing four transcription factors into fully developed adult cells, could be an effective treatment for brain injury. The appeal of iPS cells is enhanced by several factors, such as reducing the concern for stem cell shortage and the ethical concerns over the need for human embryonic cells. Furthermore, it will be possible to generate iPS cells from a patient's own tissue, negating the need for immunosuppressant drugs. The current project will study the 1) safety, 2) integration, and 3) efficacy and mechanisms of action of human iPS cells in a rodent model of stroke. In these studies human fetal and embryonic stem cells, which improve outcome following rodent models of stroke, will be compared to human iPS cells. We will first assess the risk of tumor formation following cell treatment after stroke in mice. Then we will compare the different cell treatments following rodent stroke, looking for differences in cell survival, migration, and differentiation. In the final study functional outcome and mechanisms of action such as changes in plasticity.
Competitiondate
201110
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Auriat, Angela M
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $100,000~ $0~
Direct Payment - $100,000 Grant (2011-12) | Canada Spends